Figure 4From: Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trialEffect of pasireotide on the estrogen and progesterone receptor. No significant differences were observed in the levels of estrogen receptor (ER) (A) or progesterone receptor (PR) (B) before and after treating with pasireotide.Back to article page